期刊名称：EPIGENETICS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Epigenetics is a peer-reviewed journal available in print and online. This multidisciplinary journal publishes original research articles and reviews covering the latest aspects of epigenetic mechanisms and their regulation of diverse biological processes.
Instructions to Authors
All manuscripts should be in English. Please ensure that the manuscripts are well presented and that grammar, spelling and punctuation are checked.
Text should be prepared in MS Word, double-spaced, with page numbers throughout. Papers should be written as concisely as possible in clear, grammatically correct English. DO NOT EMBED GRAPHICS WITHIN YOUR MS WORD TEXT DOCUMENT.
Organize manuscripts in the following manner:
- Title page, including titles, author's names (first, MI, last) and affiliations
- 5-10 key words (for indexing purposes)
- Acknowledgments
- A list of abbreviations and acronyms used throughout the text
- An abstract, the primary goal of which is to make the general significance and conceptual advance of the work clearly accessible to a broad readership. (References should not be cited in the abstract.
- A running title of no more than 50 characters in length
- Text (length and organization depends upon type of paper)
- References
- Tables (with descriptive titles and legends)
- Figure legends
There are no word limits for papers published, however, accepted manuscripts are published with the understanding that the first four pages are free (not all journals applied). The author will pay a charge of $80 USD for additional pages (See Color and Page Charges).
If the journal in which your paper is to be published is indexed by PubMed/Medline, the citation of your article will be sent to PubMed within one week of acceptance so please ensure all information is correct.
References for review articles are limited to 150. For Research Papers, please limit references to 85. For Addenda, and Commentaries and Views, please limit references to 30.
Include in the reference list only those articles that have been published or are in press. Unpublished data or personal communications must be cited within the text.
Please only list six authors and then use et al. Do not list less then six authors with et al.
The list of references should be numbered consecutively according to the first time mentioned within the article. Cite only the number assigned to the reference:
|
Correct: according to Jones.1
Incorrect: according to Jones1.
Correct: noted by Smith et al.1
Incorrect: Smith et al (1). |
When referring the reader to specific references as part of a sentence please state:
|
Correct: For a review see refs. 20-25.
Incorrect: For a review see 20-25 |
The reference format is the same for all of our journals. You may download the output style for Cell Cycle from Endnotes.
Abbreviate journal names according to the style used in Index Medicus or a comparable source and omit punctuation after journal titles. Spell out foreign or less commonly known journal names.
[Author's last name] [Author's initials], [First six author's last names followed by their initials]. [Title of article with only the first word capitalized]. [Journal's standard abbreviated name] [Year]; [Volume (number)]:[Inclusive pages].
- Hahn WC, Counter CM, Lundberg AS. Creation of human tumour cells with defined genetic elements. Nature 1999; 400:464-8.
- Fisher MJ, Virmani AK, Wu L, Aplenc R, Harper JC, Powell SM, et al. Nucleotide substitution in the ectodomain of trail receptor dr4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 2001; 7:1688-97.
[Author's last name] [Author's initials], [Other authors' last names followed by initials]. [Chapter title]. In: [Editor's last name] [Editor's initials], ed(s). [Book Title]. [Number of edition]. [City]:[Publisher], [Year]:[Inclusive pages].
For Example:
- Ozoren N, El-Diery WS. Introduction to cancer genes and growth control. In: Ehrlic M, ed. DNA Alterations in Cancer: Genetic and Epigenetic Changes. Natick, MA: Eaton Publishing, 2000:3-43.
Please save text and table files as Microsoft Word documents. Save tables in a file separate from text. Figure legends, however, should be at the end of the manuscript as text. Tables will be reformatted during production and therefore should only be minimally formatted in your text file.
We require figures in electronic format. They should be provided as TIFF or Photoshop files (300 dpi or greater), EPS files, Powerpoint Files or PDF files. Compatible graphics programs are Adobe Illustrator, Adobe Photoshop and Microsoft Powerpoint. Any image processing should be explained clearly in the Materials and Methods section of your manuscript.
Figures should be as small and simple as is compatible with clarity. Figures must conform to the following guidelines or authors will be asked to revise them.
Guidelines for figure preparation:
- Please be sure to embed all fonts.
- Each figure should be assembled into one file that prints onto one 8 1/2 x 11 page. Do not include separate panels on multiple pages.
- Unnecessary figures and panels in figures should be avoided: data presented in small tables or histograms, for instance, can generally be stated briefly in the text instead. Avoid unnecessary complexity, coloring and excessive detail. Figures should not contain more than one panel unless the parts are logically connected. If this is the case, each panel should be sized so that the figure as a whole can be reduced by the same amount and reproduced on the printed page at the smallest size at which essential details are visible. For figures with multiple panels, the labels should be set in uppercase Helvetica or Arial letters and should not contain periods or parentheses.
- Lettering in figures (labelling of axes and so on) should be in lower-case type, with the first letter capitalized and no full stop.
- Units should have a single space between the number and the unit, and follow SI nomenclature or the nomenclature common to a particular field. Thousands should be separated by commas (1,000). Unusual units or abbreviations should be defined in the legend.
- Scale bars should be used rather than magnification factors.
- Amino-acid sequences should be printed in Courier (or other monospaced) font using the one-letter code in lines of 50 or 100 characters.
- Layering type directly over shaded or textured areas and using reversed type (white lettering on a colored background) should be avoided.
- Where possible, text, including keys to symbols, should be provided in the legend rather than on the figure itself.
Please provide supplementary material in the following formats:
- Text: MS Word file
- Table/Data: MS Word file or Excel file
- Figures: Please provide figures in a MS Word file or in a PPT file, clearly labeled with figure legends below them.
- Please provide ALL files also in one PDF file. Links to supplemental data will be included in the PDF of the published manuscript and in the online abstract.
- Video Files: Video submissions for viewing online should be Audio Video Interleave (.avi), MPEG (.mpg), or Quick Time (.qt, .mov).
- AVI files can be displayed via Windows Media Player (http://www.microsoft.com/windows/windowsmedia/players.aspx); MPEG files can be displayed via Windows Media Player; Quick Time files require Quick Time software (free) from Apple (http://www.apple.com/quicktime/download/index.html)
- Videos should be brief whenever possible (<2-5 minutes). Longer videos will require longer download times and may have difficulty playing online. Videos should be restricted to the most critical aspects of your research. A longer procedure can be restructured as several shorter videos and submitted in that form.
- It is advisable to compress files to use as little bandwidth as possible and to avoid overly long download times. Video files should be no larger than 5 megabytes. This is a suggested maximum. If files are larger please contact Kim Mitchell.
- A caption giving a brief overall description of the video content should be provided for each video.
- If your paper is accepted for publication you may wish to supply the editorial office with several different resolutions of your video files. This will allow viewers with slower connections to download a lower resolution version of your video.
Editorial Board
Editor-in-Chief
Director, Cancer Epigenetics and Biology Program
Leader, Cancer Epigenetics Group
Barcelona, Spain
Manel Esteller (Sant Boi de Llobregat, Barcelona, Catalonia, Spain, 1968) graduated in Medicine with Honours from the University of Barcelona in 1992, where he also obtained his Ph.D. degree specialising in molecular genetics of endometrial carcinoma, in 1996. He was an Invited Researcher at the School of Biological and Medical Sciences at the University of St. Andrews, (Scotland, UK) during which time his research interests focused on the molecular genetics of inherited breast cancer. From 1997 to 2001, Esteller was a Postdoctoral Fellow and a Research Associate at the Johns Hopkins University and School of Medicine, (Baltimore, USA) where he studied DNA methylation and human cancer. His work was decisive in establishing promoter hypermethylation of tumour suppressor genes as a common hallmark of all human tumours. From October 2001 to September 2008 Manel Esteller was the Leader of the Spanish National Cancer Centre (CNIO) Cancer Epigenetics Laboratory, where his principal area of research were the alterations in DNA methylation, histone modifications and chromatin in human cancer. Since October 2008, Dr Esteller is the Director of the Cancer Epigenetics and Biology Program of the Bellvitge Institute for Biomedical Research (IDIBELL) in Barcelona and leader of the Cancer Epigenetics Group. His current research is devoted to the establishment of the epigenome maps of normal and transformed cells, the study of the interactions between epigenetic modifications and non-coding RNAs, and the development of new epigenetic drugs for cancer therapy.
Author of more than two hundred-fifty original peer-reviewed manuscripts in biomedical sciences, he is also a Member of numerous international scientific societies, Editorial Boards and reviewer for many journals and funding agencies. Dr Esteller is also Associate Editor for Cancer Research, The Lancet Oncology and Carcinogenesis, advisor of the the human epigenome projects (AHEAD, IHEC), Associate Member of the Epigenome Network of Excellence and President of the Epigenetics Society. His numerous awards include: Best Young Cancer Researcher Award bestowed by the European School of Medical Oncology (1999), First Prize in Basic Research at the Johns Hopkins University and Medical Institution (1999), Best Young Investigator Award from the European Association for Cancer Research (2000), Young Investigator Award from the American Association for Cancer Research-AFLAC (2001), Carcinogenesis Award (2005), Beckman-Coulter Award (2006), Francisco Cobos Biomedical Research Award (2006), Fondazione Piemontese per la Ricerca sul Cancro (FPRC) Award (2006), Swiss Bridge Award (2006). National Research Award in Oncology "Maria Julia Castillo" (2007), "Dr Josep Trueta" Award by the Academy of Medical Sciences of Catalonia (2007), Human Frontier Science Program Award (2007) "Dr. Jacint Vilardell" Foundation Award (2008), DEbiopharm-EPFL Award (2009), Dr. Josef Steiner Cancer Research Award (2009), Carmen y Severo Ochoa Foundation Research Award (2009) and Lilly Foundation Preclinical Biomedical Research Award (2009).
Dr Manel Esteller is the Director of the Cancer Epigenetics and Biology Program of the Bellvitge Institute for Biomedical Research (IDIBELL), Leader of the Cancer Epigenetics Group, Professor of Genetics in the School of Medicine of the University of Barcelona, and an ICREA Research Professor. He was appointed as Editor-in-Chief of Epigenetics in January 1, 2007.
Acquisitions Editor
San Diego, CA
Editorial Board
- Pierre-Olivier Angrand
- IRI@ Institut de Biologie de Lillie, CNRS; Lille, France
- Stephan Beck
- UCL Cancer Institute; London, UK
- Xiaodong Cheng
- Emory University; Atlanta, GA
- Erminio Costa
- Psychiatric Institute; Chicago, Illinois USA
- David Crews
- University of Texas; Austin, Texas USA
- Walter Doerfler
- University of Cologne; Erlangen, Germany
- Melanie Ehrlich
- Tulane University; New Orleans, Louisiana USA
- Assam El-Osta
- Baker Medical Research Institute; Victoria, Australia
- Nina Fedoroff
- Penn State University; University Park, Pennsylvania USA
- Robert Feil
- Institute of Molecular Genetics, CNRS; Montpellier, France
- Patrizia Filetici
- Universita La Sapienza; Rome, Italy
- Francois Fuks
- Free University of Brussels; Brussels, Belgium
- Dennis R. Grayson
- Psychiatric Institute; Chicago, Illinois USA
- Ueli Grossniklaus
- Institute of Plant Biology; Zurich Switzerland
- A. Guidotti
- Psychiatric Institute; Chicago, Illinois USA
- Lin He
- Shanghai Jiao Tong University; Shanghai, China
- Randy Jirtle
- Duke University; Durham, North Carolina USA
- Victor Lobanekov
- National Institute of Allergy and Infectious Diseases; Rockville, Maryland USA
- Michael Meaney
- McGill University; Montreal, Canada
- Barbara R. Migeon
- Johns Hopkins University; Baltimore, Maryland USA
- Rolf Ohlsson
- Uppsala University; Uppsala, Sweden
|
